BLISS GVS PHARMA
|
The Current P/S Ratio of BLISS GVS PHARMA is 3.43.
| Share Price | ₹300.2 | May 22,2026 |
| Market Cap | ₹3,176.1 Cr | |
| Sales-TTM | ₹927.1 Cr | TTM-Consolidated Results |
| Price/Sales | 3.43x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BLISS GVS PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹3,176.1 Cr] as on May 22,2026
(/) Sales [ ₹927.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.43x ]
Thus, for BLISS GVS PHARMA , the investors are currently willing to pay '3.43 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BLISS GVS PHARMA !
The chart below summarizes the trend in P/S Ratio of BLISS GVS PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BLISS GVS PHARMA
PS Ratio Performance Analysis for BLISS GVS PHARMA
- BLISS GVS PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.38x.
- BLISS GVS PHARMA 's operated at median p/e ratio of 1.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BLISS GVS PHARMA 's p/e ratio peaked in Mar2021 at 1.76x.
- BLISS GVS PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0.99x.
How does BLISS GVS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BLISS GVS PHARMA | 927.1 | 3.43 | 3,176.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.57 | 442,725.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 17.72 | 182,775.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.86 | 151,764.0 |
| CIPLA LTD | 28,162.6 | 4.01 | 113,007.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.24 | 109,098.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.17 | 102,422.0 |
| LUPIN LTD | 27,958.0 | 3.73 | 104,222.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.85 | 104,543.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.50 | 84,272.7 |
| LAURUS LABS LTD | 6,812.9 | 10.64 | 72,518.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BLISS GVS PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.50x |
| Max industry PS | 17.72x |
| Median industry PS | 4.01x |
| Average industry PS | 6.79x |
You may also like the below Video Courses